Federated Hermes
BIOR

Federated Hermes’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Federated Hermes’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-370
Closed -$835K – 2378
2020
Q3 		$835K Sell
370
-30
-8% -$67.8K ﹤0.01% 1311
2020
Q2 		$900K Buy
+400
New +$1.09M ﹤0.01% 1285

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes's BIOR Position: Q4 2020 in Review

Federated Hermes sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2020, closing a stake of 370 shares — an estimated $835K sold.

Federated Hermes first reported a position in BIOR in Q2 2020 and held it in 2 quarters. The position peaked at $900K in Q2 2020. 48 funds tracked by Wall St. Rank hold BIOR as of Q4 2020.

  • Federated Hermes reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 370 Biora Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $835K.
  • Federated Hermes first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Federated Hermes's Biora Therapeutics, Inc. Common Stock position peaked at $900K in Q2 2020.
  • 48 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.